Formulary Management of Targeted Immune Modulators for Ulcerative Colitis: Environmental Scan

Details

Files
Project Status:
Completed
Project Line:
Health Technology Review
Project Sub Line:
Environmental Scan
Project Number:
ES0366-000
Effective finish date:

An assessment of the current reimbursement of targeted immune modulators (TIMs) used to treat adults with moderate to severe ulcerative colitis (UC) is needed given the significant expenditures in Canada on biologic drugs, as well as the changing dynamics with regards to loss of exclusivity market entry of new drugs, and availability of new evidence. This Environmental Scan will assess the regulatory, exclusivity, CADTH review, and reimbursement status of TIMs for UC relevant to public drug plans.